E-cadherin levels in premalignant and malignant oral lesions — a systematic review
Originally at link.springer.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Oral surgeons, periodontists, and oral pathologists may encounter E-cadherin testing in premalignant and malignant oral lesions; understanding current evidence levels helps calibrate diagnostic expectations and patient counseling.
Key points
- BMC Oral Health publishes a systematic review titled 'E-cadherin levels in premalignant and malignant oral lesions.'
- Review compiles published studies that compare E-cadherin expression between premalignant and malignant oral lesions.
- Article evaluates the potential diagnostic or prognostic role of E-cadherin in oral epithelial lesions.
- Review draws only from existing peer-reviewed studies and does not introduce new clinical data.
Who should care
Read the original on BMC Oral Health
Full reporting and any paywall content live on link.springer.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Prosthodontist accused of running drug ‘party house’
- ·Research
Masseter muscle volume and cross-sectional area as risk factors
- ·Research
The association between parafunctional oral habits
- ·Regulatory
Groups propose legislation allowing West Virginia dentists, hygienists to administer HPV vaccine